The global ophthalmic eye drop market is poised for steady growth over the next decade. The market, which was valued at USD ...

2024年9月4日至8日，中华医学会第二十八次眼科学术大会（CCOS ...

Browse 413 market data Tables and 56 Figures spread through 474 Pages and in-depth TOC on "Ophthalmic Equipment Market by ...

The FDA has issued a warning letter to Regenerative Processing Plant after conducting an inspection of the facility. The plant manufactures two ophthalmic drug products, Regener-Eyes Professional ...

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma ...

Top-line data from VEGA-3 Phase 3 trial expected in first half of 2025Top-line data from LYNX-2 Phase 3 trial in patients with decreased visual ...

APP13007 is the first US FDA-approved ophthalmic solution featuring the super-potent corticosteroid clobetasol propionate.

Harrow's CEO Mark Baum transforms a struggling company into a leader in ophthalmic drugs, with growth in branded products & ...

Ocuphire anticipates using data obtained from the VEGA-3 trial demonstrating the efficacy and safety of Phentolamine Ophthalmic Solution 0.75% as a potential treatment for presbyopia to support a ...

The Topcon Healthcare solution includes a full eye examination suite as well as its NW500 retinal camera, Maestro 2 OCT, ...